Prediction of histological grading in ductal carcinoma in situ based on mammographic signs and clinical information using machine learning models - Report - MDSpire

Prediction of histological grading in ductal carcinoma in situ based on mammographic signs and clinical information using machine learning models

  • By

  • Jianyu Wang

  • Shilu Zhao

  • Liuying Zhao

  • Furong Huang

  • Hao Wu

  • Da Pang

  • July 2, 2026

  • 0 min

Share

Clinical Report: Utilizing Machine Learning Models to Forecast Histological Grading in DCIS

Overview

This study evaluates the use of machine learning models to predict histological grading in ductal carcinoma in situ (DCIS) using mammographic indicators and clinical data. The models demonstrated varying performance, with multinomial Naive Bayes achieving the highest area under the curve (AUC) values.

Background

Ductal carcinoma in situ (DCIS) is a non-invasive breast cancer that can progress to invasive disease if not accurately diagnosed and managed. Histological grading of DCIS is crucial for guiding treatment decisions, yet current grading methods face challenges such as inter-observer variability. The integration of machine learning with clinical and mammographic data may enhance the accuracy of DCIS grading.

Data Highlights

ModelTraining AUCTest AUCAccuracySensitivitySpecificity
XGBoost0.7880.7630.7610.7260.725
Logistic Regression0.7960.7560.7580.8240.692
Multinomial Naive Bayes0.8060.7840.7760.8080.744

Key Findings

  • The study included 243 patients diagnosed with breast DCIS.
  • Histological grading categorized patients into non-high-grade (n=110) and high-grade (n=133) groups.
  • Machine learning models developed included eXtreme Gradient Boosting (XGBoost), logistic regression (LR), and multinomial Naive Bayes (MNB).
  • MNB achieved the highest training AUC of 0.806 and test AUC of 0.784.
  • All models showed comparable performance with no statistically significant differences in AUC (p > 0.05).
  • Integration of mammographic features and clinical data may enhance DCIS grading accuracy.

Clinical Implications

Further validation in multi-center studies is necessary to confirm these results.

Conclusion

Machine learning models show potential in predicting histological grading in DCIS, with MNB demonstrating the highest AUC values. Further investigation is warranted to validate their clinical utility.

Related Resources & Content

  1. European Radiology, 2025 -- Evaluating Breast Cancer Risk for Screening Using a Combined Artificial Intelligence Method
  2. DIGITAL HEALTH, 2022 -- Development and validation of a machine learning model for predicting invasive breast cancer using 26 routine clinical examination indicators
  3. European Radiology, 2025 -- A Deep Learning Approach for Classifying Grade 2 Nottingham Histologic Breast Tumors Using Dynamic Contrast-Enhanced MRI
  4. Int. Journal of Computer Assisted Radiology and Surgery, 2026 -- Estimation of histopathological types from breast MRI findings using a large language model
  5. Management of Ductal Carcinoma In Situ: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline - PMC, 2024
  6. Management of Ductal Carcinoma In Situ: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline - PMC
  7. Checking your browser - reCAPTCHA
  8. Clinicopathological and prognostic value of calcification morphology descriptors in ductal carcinoma in situ of the breast: a systematic review and meta-analysis - PMC

Original Source(s)

Related Content